Research Paper Volume 11, Issue 16 pp 6555—6568

LAV-BPIFB4 associates with reduced frailty in humans and its transfer prevents frailty progression in old mice


Figure 2. Survival function of: (A) LAV Homozygous carriers and (B) RV carriers (solid line) vs others (dotted line) in the Calabria cohort. Time is expressed in months, where 0 is considered the time of recruitment, and each individual is followed up for survival status till death. Adjusted HR and p-values are reported inside the Figure.